GlassScriptPhysician profile
Thomas B Lintner
NPI 1376697565
$3,715.09
in general payments reported to CMS, 2019-2025
12 companies · $371 in 2025
The $371 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $481 · 2020: $1,987 · 2021: $75.57 · 2022: $221 · 2023: $294 · 2024: $285 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $950.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $1,977.45 | 2019-2022 | |
| Mentor Worldwide LLC | $627.45 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $575.17 | 2019-2022 | |
| Abbvie INC. | $296.60 | 2023-2025 | |
| Integra Lifesciences Corporation | $68.06 | 2023-2024 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Sientra, INC. | $38.16 | 2019 | |
| Tela Bio, INC. | $31.93 | 2024 | Ovitex 2s |
| Merz North America, INC. | $31.50 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $22.47 | 2024 | Caldolor |
| Medtronic USA, INC. | $16.80 | 2019 | |
| Meditrina | $15.82 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Lintner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.